FDA — authorised 17 August 1978
- Application: NDA018044
- Marketing authorisation holder: ESJAY PHARMA
- Status: supplemented
FDA authorised Vitamin D3 as "BABY D3" on 17 August 1978
Yes. FDA authorised it on 17 August 1978; FDA authorised it on 12 October 2001; FDA authorised it on 27 March 2006.
ESJAY PHARMA holds the US marketing authorisation.